atorvastatin has been researched along with Cardiac Rupture, Traumatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Z; Li, F; Li, Y; Sun, J | 1 |
| Cui, W; Du, H; Hao, J; Li, WW; Liu, F; Lu, JC; Yang, XC; Zhao, ZF | 1 |
| Chello, M; Colonna, D; Covino, E; D'Ambrosio, A; Di Sciascio, G; Miglionico, M; Nusca, A; Pasceri, V; Patti, G | 1 |
2 trial(s) available for atorvastatin and Cardiac Rupture, Traumatic
| Article | Year |
|---|---|
Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Combined Modality Therapy; Drug Therapy, Combination; Female; Heart Injuries; Humans; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Period; Postoperative Complications; Trimetazidine; Troponin I; Tumor Necrosis Factor-alpha | 2015 |
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-C
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Atorvastatin; Cardiotonic Agents; Cell Adhesion Molecules; Coronary Disease; E-Selectin; Heart Injuries; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Intercellular Adhesion Molecule-1; Multicenter Studies as Topic; Pyrroles; Vascular Cell Adhesion Molecule-1 | 2006 |
1 other study(ies) available for atorvastatin and Cardiac Rupture, Traumatic